AnaptysBio Inc buy UBS Group AG
Start price
13.05.26
/
50%
€54.40
Target price
13.05.27
-
Performance (%)
-10.96%
Price
13.08.26
€48.44
Summary
This prediction is currently active. The prediction for AnaptysBio Inc disappoints with a performance of -10.96%. This prediction currently runs until 13.05.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 2.758% | 2.758% |
| iShares Core DAX® | 0,44 % | 5,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for ANAB provided by MarketBeat